Trending

Tagrisso

AZ’s new cancer drugs drive another stellar quarter

AZ’s new cancer drugs drive another stellar quarter

AstraZeneca has raised its sales guidance of the year once again as its trio of new cancer drugs

X

AZ’s new cancer drugs drive another stellar quarter

https://pharmaphorum.com/news/azs-new-cancer-drugs-drive-another-stellar-quarter/

AZ gets China nod for Tagrisso in first-line lung cancer

AZ gets China nod for Tagrisso in first-line lung cancer

AstraZeneca has scored another approval for one of its new drugs in China, this time getting a green

X

AZ gets China nod for Tagrisso in first-line lung cancer

https://pharmaphorum.com/news/az-gets-china-nod-for-tagrisso-in-first-line-lung-cancer/

AstraZeneca gets further approval for Tagrisso in Japan

AstraZeneca gets further approval for Tagrisso in Japan

AstraZeneca received approval from the Japanese regulator following a priority review of Tagrisso (osimertinib) as a first-line treatment

X

AstraZeneca gets further approval for Tagrisso in Japan

https://pharmaphorum.com/news/astrazeneca-tagrisso-approval/

AZ’s Tagrisso wins new NSCLC first-line approval in Europe

AZ’s Tagrisso wins new NSCLC first-line approval in Europe

AstraZeneca has widened the licence for its cancer drug Tagrisso (osimertinib) in Europe after regulators gave it the

X

AZ’s Tagrisso wins new NSCLC first-line approval in Europe

https://pharmaphorum.com/news/az-tagrisso-nsclc-egfr-europe/

AZ’s Tagrisso gets full US approval in lung cancer

AZ’s Tagrisso gets full US approval in lung cancer

Phase 3 data confirmed its efficacy in patients with a certain mutation.

X

AZ’s Tagrisso gets full US approval in lung cancer

https://pharmaphorum.com/news/azs-tagrisso-gets-full-us-approval-lung-cancer/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com